HHS Identifies Drug Price Targets to Advance Most Favored Nations Policy
- May 23, 2025
Drug manufacturers will be expected to align their pricing in the United States for all brand products that do not have generic or biosimilar competition with the lowest price of “economic peer countries,” the Department of Health and Human Services (HHS) announced May 20.
ARTICLE TAGS
You must be logged in to access this content.